866-997-4948(US-Canada Toll Free)

Colorectal Cancer - Pipeline Review, H2 2015

Published By :

Global Markets Direct

Published Date : Dec 2015

Category :

Cancer

No. of Pages : 1511 Pages

Colorectal Cancer - Pipeline Review, H2 2015

Summary

Global Markets Directs, Colorectal Cancer - Pipeline Review, H2 2015, provides an overview of the Colorectal Cancers therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colorectal Cancer and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Colorectal Cancer
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Colorectal Cancer and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Colorectal Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Colorectal Cancer pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Colorectal Cancer
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Colorectal Cancer pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2
Introduction 11
Colorectal Cancer Overview 12
Therapeutics Development 13
Colorectal Cancer - Therapeutics under Development by Companies 15
Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes 34
Colorectal Cancer - Pipeline Products Glance 37
Colorectal Cancer - Products under Development by Companies 41
Colorectal Cancer - Products under Investigation by Universities/Institutes 65
Colorectal Cancer - Companies Involved in Therapeutics Development 68
Colorectal Cancer - Therapeutics Assessment 275
Drug Profiles 312
Colorectal Cancer - Recent Pipeline Updates 1021
Colorectal Cancer - Dormant Projects 1428
Colorectal Cancer - Discontinued Products 1452
Colorectal Cancer - Product Development Milestones 1459
Appendix 1467

List of Tables
Number of Products under Development for Colorectal Cancer, H2 2015 56
Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2015 57
Number of Products under Development by Companies, H2 2015 59
Number of Products under Development by Companies, H2 2015 (Contd..1) 60
Number of Products under Development by Companies, H2 2015 (Contd..2) 61
Number of Products under Development by Companies, H2 2015 (Contd..3) 62
Number of Products under Development by Companies, H2 2015 (Contd..4) 63
Number of Products under Development by Companies, H2 2015 (Contd..5) 64
Number of Products under Development by Companies, H2 2015 (Contd..6) 65
Number of Products under Development by Companies, H2 2015 (Contd..7) 66
Number of Products under Development by Companies, H2 2015 (Contd..8) 67
Number of Products under Development by Companies, H2 2015 (Contd..9) 68
Number of Products under Development by Companies, H2 2015 (Contd..10) 69
Number of Products under Development by Companies, H2 2015 (Contd..11) 70
Number of Products under Development by Companies, H2 2015 (Contd..12) 71
Number of Products under Development by Companies, H2 2015 (Contd..13) 72
Number of Products under Development by Companies, H2 2015 (Contd..14) 73
Number of Products under Development by Companies, H2 2015 (Contd..15) 74
Number of Products under Development by Companies, H2 2015 (Contd..16) 75
Number of Products under Development by Companies, H2 2015 (Contd..17) 76
Number of Products under Investigation by Universities/Institutes, H2 2015 77
Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..1) 78
Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..2) 79
Comparative Analysis by Late Stage Development, H2 2015 80
Comparative Analysis by Clinical Stage Development, H2 2015 81
Comparative Analysis by Early Stage Development, H2 2015 82
Comparative Analysis by Unknown Stage Development, H2 2015 83
Products under Development by Companies, H2 2015 84
Products under Development by Companies, H2 2015 (Contd..1) 85
Products under Development by Companies, H2 2015 (Contd..2) 86
Products under Development by Companies, H2 2015 (Contd..3) 87
Products under Development by Companies, H2 2015 (Contd..4) 88
Products under Development by Companies, H2 2015 (Contd..5) 89
Products under Development by Companies, H2 2015 (Contd..6) 90
Products under Development by Companies, H2 2015 (Contd..7) 91
Products under Development by Companies, H2 2015 (Contd..8) 92
Products under Development by Companies, H2 2015 (Contd..9) 93
Products under Development by Companies, H2 2015 (Contd..10) 94
Products under Development by Companies, H2 2015 (Contd..11) 95
Products under Development by Companies, H2 2015 (Contd..12) 96
Products under Development by Companies, H2 2015 (Contd..13) 97
Products under Development by Companies, H2 2015 (Contd..14) 98
Products under Development by Companies, H2 2015 (Contd..15) 99
Products under Development by Companies, H2 2015 (Contd..16) 100
Products under Development by Companies, H2 2015 (Contd..17) 101
Products under Development by Companies, H2 2015 (Contd..18) 102
Products under Development by Companies, H2 2015 (Contd..19) 103
Products under Development by Companies, H2 2015 (Contd..20) 104
Products under Development by Companies, H2 2015 (Contd..21) 105
Products under Development by Companies, H2 2015 (Contd..22) 106
Products under Development by Companies, H2 2015 (Contd..23) 107
Products under Investigation by Universities/Institutes, H2 2015 108
Products under Investigation by Universities/Institutes, H2 2015 (Contd..1) 109
Products under Investigation by Universities/Institutes, H2 2015 (Contd..2) 110
Colorectal Cancer - Pipeline by 2cureX ApS, H2 2015 111
Colorectal Cancer - Pipeline by 3-V Biosciences, Inc., H2 2015 112
Colorectal Cancer - Pipeline by 4SC AG, H2 2015 113
Colorectal Cancer - Pipeline by AB Science SA, H2 2015 114
Colorectal Cancer - Pipeline by AbbVie Inc., H2 2015 115
Colorectal Cancer - Pipeline by AbGenomics International, Inc., H2 2015 116
Colorectal Cancer - Pipeline by Actinium Pharmaceuticals, Inc., H2 2015 117
Colorectal Cancer - Pipeline by Adamed Sp. z o.o., H2 2015 118
Colorectal Cancer - Pipeline by Advaxis, Inc., H2 2015 119
Colorectal Cancer - Pipeline by Advenchen Laboratories, LLC, H2 2015 120
Colorectal Cancer - Pipeline by Alchemia Limited, H2 2015 121
Colorectal Cancer - Pipeline by Allinky Biopharma, H2 2015 122
Colorectal Cancer - Pipeline by Amgen Inc., H2 2015 123
Colorectal Cancer - Pipeline by Antibe Therapeutics, Inc., H2 2015 124
Colorectal Cancer - Pipeline by Apexigen, Inc., H2 2015 125
Colorectal Cancer - Pipeline by Aphios Corporation, H2 2015 126
Colorectal Cancer - Pipeline by Aposense Ltd., H2 2015 127
Colorectal Cancer - Pipeline by Arisaph Pharmaceuticals, Inc., H2 2015 128
Colorectal Cancer - Pipeline by ArQule, Inc., H2 2015 129
Colorectal Cancer - Pipeline by Array BioPharma Inc., H2 2015 130
Colorectal Cancer - Pipeline by Astellas Pharma Inc., H2 2015 131
Colorectal Cancer - Pipeline by Astex Pharmaceuticals, Inc., H2 2015 132
Colorectal Cancer - Pipeline by AstraZeneca Plc, H2 2015 133
Colorectal Cancer - Pipeline by ATLAB Pharma SAS, H2 2015 134
Colorectal Cancer - Pipeline by AVEO Pharmaceuticals, Inc., H2 2015 135
Colorectal Cancer - Pipeline by Basilea Pharmaceutica AG, H2 2015 136
Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H2 2015 137
Colorectal Cancer - Pipeline by Baxalta Incorporated, H2 2015 138
Colorectal Cancer - Pipeline by Bayer AG, H2 2015 139
Colorectal Cancer - Pipeline by BeiGene(Beijing) Co.,Ltd, H2 2015 140
Colorectal Cancer - Pipeline by BioAtla, LLC, H2 2015 141
Colorectal Cancer - Pipeline by Biocon Limited, H2 2015 142
Colorectal Cancer - Pipeline by Bionomics Limited, H2 2015 143
Colorectal Cancer - Pipeline by Bionovis SA, H2 2015 144
Colorectal Cancer - Pipeline by Biotecnol, Inc., H2 2015 145
Colorectal Cancer - Pipeline by Biothera, Inc., H2 2015 146
Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2015 147
Colorectal Cancer - Pipeline by Boston Biomedical, Inc., H2 2015 148
Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2015 149
Colorectal Cancer - Pipeline by Burzynski Research Institute, Inc., H2 2015 150
Colorectal Cancer - Pipeline by cCAM Biotherapeutics Ltd., H2 2015 151
Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H2 2015 152
Colorectal Cancer - Pipeline by Celator Pharmaceuticals, Inc., H2 2015 153
Colorectal Cancer - Pipeline by Celgene Corporation, H2 2015 154
Colorectal Cancer - Pipeline by Cellceutix Corporation, H2 2015 155
Colorectal Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2015 156
Colorectal Cancer - Pipeline by Cellectar Biosciences, Inc., H2 2015 157
Colorectal Cancer - Pipeline by Celltrion, Inc., H2 2015 158
Colorectal Cancer - Pipeline by Celon Pharma Sp. z o.o., H2 2015 159
Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2015 160
Colorectal Cancer - Pipeline by Cleave Biosciences, H2 2015 161
Colorectal Cancer - Pipeline by Coare Biotechnology, Inc., H2 2015 162
Colorectal Cancer - Pipeline by Cornerstone Pharmaceuticals, Inc., H2 2015 163
Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2015 164
Colorectal Cancer - Pipeline by CritiTech, Inc., H2 2015 165
Colorectal Cancer - Pipeline by CrystalGenomics, Inc., H2 2015 166
Colorectal Cancer - Pipeline by CTI BioPharma Corp., H2 2015 167
Colorectal Cancer - Pipeline by Cytune Pharma SAS, H2 2015 168
Colorectal Cancer - Pipeline by Daiichi Sankyo Company, Limited, H2 2015 169
Colorectal Cancer - Pipeline by DanDrit Biotech A/S, H2 2015 170
Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals, LLC, H2 2015 171
Colorectal Cancer - Pipeline by Dicerna Pharmaceuticals, Inc., H2 2015 172
Colorectal Cancer - Pipeline by Digna Biotech, S.L., H2 2015 173
Colorectal Cancer - Pipeline by Double Bond Pharmaceutical International AB, H2 2015 174
Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Limited, H2 2015 175
Colorectal Cancer - Pipeline by EirGenix Inc., H2 2015 176
Colorectal Cancer - Pipeline by Eisai Co., Ltd., H2 2015 177
Colorectal Cancer - Pipeline by Eli Lilly and Company, H2 2015 178
Colorectal Cancer - Pipeline by Endor Nanotechnologies SL, H2 2015 179
Colorectal Cancer - Pipeline by enGene, Inc, H2 2015 180
Colorectal Cancer - Pipeline by EnGeneIC Ltd, H2 2015 181
Colorectal Cancer - Pipeline by Ensol Biosciences Inc., H2 2015 182
Colorectal Cancer - Pipeline by EntreChem, S.L., H2 2015 183
Colorectal Cancer - Pipeline by Enzo Biochem, Inc., H2 2015 184
Colorectal Cancer - Pipeline by Epirus Biopharmaceuticals, Inc., H2 2015 185
Colorectal Cancer - Pipeline by Erytech Pharma SA, H2 2015 186
Colorectal Cancer - Pipeline by Etubics Corporation, H2 2015 187
Colorectal Cancer - Pipeline by Exelixis, Inc., H2 2015 188
Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015 189
Colorectal Cancer - Pipeline by Five Prime Therapeutics, Inc., H2 2015 190
Colorectal Cancer - Pipeline by Fusion Antibodies Limited, H2 2015 191
Colorectal Cancer - Pipeline by Genentech, Inc., H2 2015 192
Colorectal Cancer - Pipeline by Genor BioPharma Co., Ltd., H2 2015 193
Colorectal Cancer - Pipeline by Genoscience Pharma, H2 2015 194
Colorectal Cancer - Pipeline by Genzyme Corporation, H2 2015 195
Colorectal Cancer - Pipeline by GlaxoSmithKline Plc, H2 2015 196
Colorectal Cancer - Pipeline by Glycotope GmbH, H2 2015 197
Colorectal Cancer - Pipeline by Golden Biotechnology Corp., H2 2015 198
Colorectal Cancer - Pipeline by Green Cross Corporation, H2 2015 199
Colorectal Cancer - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2015 200
Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2015 201
Colorectal Cancer - Pipeline by Hemispherx Biopharma, Inc., H2 2015 202
Colorectal Cancer - Pipeline by Hetero Drugs Limited, H2 2015 203
Colorectal Cancer - Pipeline by Hospira, Inc., H2 2015 204
Colorectal Cancer - Pipeline by Hutchison MediPharma Limited, H2 2015 205
Colorectal Cancer - Pipeline by iDD biotech SAS, H2 2015 206
Colorectal Cancer - Pipeline by Ignyta, Inc., H2 2015 207
Colorectal Cancer - Pipeline by immatics biotechnologies GmbH, H2 2015 208
Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd., H2 2015 209
Colorectal Cancer - Pipeline by ImmuneXcite, Inc., H2 2015 210
Colorectal Cancer - Pipeline by ImmunNovative Developments SL, H2 2015 211
Colorectal Cancer - Pipeline by Immunomedics, Inc., H2 2015 212
Colorectal Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2015 213
Colorectal Cancer - Pipeline by Inbiopro Solutions Pvt. Ltd., H2 2015 214
Colorectal Cancer - Pipeline by Incanthera Ltd., H2 2015 215
Colorectal Cancer - Pipeline by Incyte Corporation, H2 2015 216
Colorectal Cancer - Pipeline by Innovent Biologics, Inc., H2 2015 217
Colorectal Cancer - Pipeline by Interprotein Corporation, H2 2015 218
Colorectal Cancer - Pipeline by Ionis Pharmaceuticals, Inc., H2 2015 219
Colorectal Cancer - Pipeline by Isofol Medical AB, H2 2015 220
Colorectal Cancer - Pipeline by ISU ABXIS Co.,Ltd., H2 2015 221
Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2015 222
Colorectal Cancer - Pipeline by Kadmon Corporation, LLC, H2 2015 223
Colorectal Cancer - Pipeline by KAEL-GemVax Co., Ltd., H2 2015 224
Colorectal Cancer - Pipeline by KaloBios Pharmaceuticals, Inc., H2 2015 225
Colorectal Cancer - Pipeline by Kancera AB, H2 2015 226
Colorectal Cancer - Pipeline by Karyopharm Therapeutics, Inc., H2 2015 227
Colorectal Cancer - Pipeline by Kura Oncology, Inc., H2 2015 228
Colorectal Cancer - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2015 229
Colorectal Cancer - Pipeline by Laboratorio Elea S.A.C.I.F. and A, H2 2015 230
Colorectal Cancer - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2015 231
Colorectal Cancer - Pipeline by LivTech, Inc., H2 2015 232
Colorectal Cancer - Pipeline by Loxo Oncology, Inc., H2 2015 233
Colorectal Cancer - Pipeline by Mabion SA, H2 2015 234
Colorectal Cancer - Pipeline by Mabtech Limited, H2 2015 235
Colorectal Cancer - Pipeline by mAbxience S.A., H2 2015 236
Colorectal Cancer - Pipeline by MacroGenics, Inc., H2 2015 237
Colorectal Cancer - Pipeline by MedImmune, LLC, H2 2015 238
Colorectal Cancer - Pipeline by Medivation, Inc., H2 2015 239
Colorectal Cancer - Pipeline by Merck & Co., Inc., H2 2015 240
Colorectal Cancer - Pipeline by Merck KGaA, H2 2015 241
Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2015 242
Colorectal Cancer - Pipeline by Merus B.V., H2 2015 243
Colorectal Cancer - Pipeline by Millennium Pharmaceuticals, Inc., H2 2015 244
Colorectal Cancer - Pipeline by Mirna Therapeutics, Inc., H2 2015 245
Colorectal Cancer - Pipeline by MolMed S.p.A., H2 2015 246
Colorectal Cancer - Pipeline by Mologen AG, H2 2015 247
Colorectal Cancer - Pipeline by Momenta Pharmaceuticals, Inc., H2 2015 248
Colorectal Cancer - Pipeline by Morphotek, Inc., H2 2015 249
Colorectal Cancer - Pipeline by Multimmune GmbH, H2 2015 250
Colorectal Cancer - Pipeline by Mycenax Biotech Inc., H2 2015 251
Colorectal Cancer - Pipeline by Natco Pharma Limited, H2 2015 252
Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corporation, H2 2015 253
Colorectal Cancer - Pipeline by Nektar Therapeutics, H2 2015 254
Colorectal Cancer - Pipeline by Neovacs SA, H2 2015 255
Colorectal Cancer - Pipeline by Nerviano Medical Sciences S.r.l., H2 2015 256
Colorectal Cancer - Pipeline by Nippon Kayaku Co., Ltd., H2 2015 257
Colorectal Cancer - Pipeline by NormOxys, Inc., H2 2015 258
Colorectal Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2015 259
Colorectal Cancer - Pipeline by Novartis AG, H2 2015 260
Colorectal Cancer - Pipeline by NuCana BioMed Limited, H2 2015 261
Colorectal Cancer - Pipeline by OBI Pharma, Inc., H2 2015 262
Colorectal Cancer - Pipeline by Oncobiologics, Inc., H2 2015 263
Colorectal Cancer - Pipeline by Oncology Research International Limited, H2 2015 264
Colorectal Cancer - Pipeline by Oncolytics Biotech Inc., H2 2015 265
Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals, Inc., H2 2015 266
Colorectal Cancer - Pipeline by Onconova Therapeutics, Inc., H2 2015 267
Colorectal Cancer - Pipeline by Oncothyreon Inc., H2 2015 268
Colorectal Cancer - Pipeline by Oryx GmbH & Co. KG, H2 2015 269
Colorectal Cancer - Pipeline by Otsuka Holdings Co., Ltd., H2 2015 270
Colorectal Cancer - Pipeline by Oxford BioMedica Plc, H2 2015 271
Colorectal Cancer - Pipeline by Panacea Biotec Limited, H2 2015 272
Colorectal Cancer - Pipeline by Pfizer Inc., H2 2015 273
Colorectal Cancer - Pipeline by Pharma Mar, S.A., H2 2015 274

List of Figures
Number of Products under Development for Colorectal Cancer, H2 2015 56
Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2015 57
Number of Products under Development by Companies, H2 2015 58
Number of Products under Investigation by Universities/Institutes, H2 2015 77
Comparative Analysis by Late Stage Development, H2 2015 80
Comparative Analysis by Clinical Stage Development, H2 2015 81
Comparative Analysis by Early Stage Products, H2 2015 82
Assessment by Monotherapy Products, H2 2015 318
Assessment by Combination Products, H2 2015 319
Number of Products by Top 10 Targets, H2 2015 320
Number of Products by Stage and Top 10 Targets, H2 2015 320
Number of Products by Top 10 Mechanism of Actions, H2 2015 338
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 338
Number of Products by Top 10 Routes of Administration, H2 2015 351
Number of Products by Stage and Top 10 Routes of Administration, H2 2015 351
Number of Products by Top 10 Molecule Types, H2 2015 353
Number of Products by Stage and Top 10 Molecule Types, H2 2015 353

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *